slides · global inventory
Image
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 119,566
Current window 91,411-91,440
Pages 3,986
Rows per page 30
Component
91,411-91,440 of 119,566
01
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
09
Scientific diagram illustrating the mechanism of antigen presentation and T cell maturation.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
10
The slide uses a biological diagram to explain the 'problem' of immune evasion in cancer therapy.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
11
The diagram uses a funnel-like or layered process flow to map biological mechanisms to specific immune outcomes.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
16
The slide presents two bar charts (weight and volume) and a grid of tumor photographs as visual proof of concept.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
17
Includes visual evidence of tumor size alongside quantitative bar charts with statistical significance markers.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
22
The slide uses immunohistochemistry (brown staining) to visualize CD4+ T-cells, quantified in the bar chart.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
23
The slide uses immunohistochemistry images and a corresponding bar chart to demonstrate efficacy.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
28
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
07
The slide uses a matrix structure to map clinical assets to specific indications and trial names.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
08
The diagram shows the MAPK pathway inhibition. The patient population data is presented as a simple table.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
13
Includes a biological diagram illustrating the RAS protein state transition and mutation impact.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
30
The slide uses a biological diagram to illustrate EGFR mutations in GBM.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
31
The slide uses western blot data to demonstrate potency and a table to demonstrate pharmacokinetic superiority in mouse models.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
32
The chart is a Kaplan-Meier survival plot comparing three treatment groups.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
36
Features the Lorenz attractor graphic, which is a signature visual for Erasca.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
40
The slide uses western blot imagery to show protein expression levels (P-RSK, P-ERK, GAPDH) over time (0-72h) to prove the efficacy of ERAS-007.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations 1 hit
02
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Setup1 hit
04
The slide uses a split-screen layout with a solid magenta background on the left and a group photo on the right.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Setup1 hit
06
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
08
The slide uses a background image of people to convey a brand-focused message, with a white overlay containing the logos.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
13
The slide uses a grid of circular callouts to present financial KPIs.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
22
Uses a timeline-style layout to present distinct strategic pillars.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
24
The slide highlights five specific product categories or launches under the Tork brand.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Reflection1 hit
25
The slide uses a brand-specific image of a baby to reinforce the 'Libero' brand context.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Reflection1 hit
27
The slide uses a mix of corporate financial reporting and product marketing imagery.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Reflection1 hit
29
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations 1 hit
30
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations 1 hit
03
The slide uses a split-screen layout to contrast internal R&D with external partnerships, unified by a central 'discovery programmes' stack.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
17
Exscientia | Investor Day Presentation Deck | 90 slidesExscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit